Operating
Stock-Based Comp
West Pharmaceutical Services Stock-Based Comp decreased by 1.5% to $6.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 407.7%, from $1.30M to $6.60M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows a downward trend with a -10.7% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
Detailed definition
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Peer comparison
Standard across large-cap corporations; varies based on corporate compensation philosophy.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.30M | $11.30M | $10.00M | $5.50M | $5.50M | $6.00M | $6.70M | $8.50M | $7.50M | $5.90M | $1.40M | $5.00M | $4.30M | $5.10M | $4.30M | $1.30M | $7.40M | $8.40M | $6.70M | $6.60M |
| QoQ Change | — | +9.7% | -11.5% | -45.0% | +0.0% | +9.1% | +11.7% | +26.9% | -11.8% | -21.3% | -76.3% | +257.1% | -14.0% | +18.6% | -15.7% | -69.8% | +469.2% | +13.5% | -20.2% | -1.5% |
| YoY Change | — | — | — | — | -46.6% | -46.9% | -33.0% | +54.5% | +36.4% | -1.7% | -79.1% | -41.2% | -42.7% | -13.6% | +207.1% | -74.0% | +72.1% | +64.7% | +55.8% | +407.7% |
Range$1.30M – $11.30M
CAGR-8.9%
Avg YoY Growth+32.5%
Median YoY Growth-7.6%
Current Streak2 quarters decline
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's stock-based comp?
- West Pharmaceutical Services (WST) reported stock-based comp of $6.60M in Q1 2026.
- How has West Pharmaceutical Services's stock-based comp changed year-over-year?
- West Pharmaceutical Services's stock-based comp increased by 407.7% year-over-year, from $1.30M to $6.60M.
- What is the long-term trend for West Pharmaceutical Services's stock-based comp?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's stock-based comp has grown at a -10.7% compound annual growth rate (CAGR), from $37.50M to $23.80M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock instead of cash.